Saturday, Dec 20th
Last update10:11:42 AM GMT
Eli Lilly & Co. trained its sales force to downplay risks for Zyprexa and encourage doctors to prescribe the drug beyond approved uses for schizophrenia and bipolar disorder, according to court documents.
Lilly's research showed some patients on Zyprexa gained as much as 80 pounds and that the incidence of high blood sugar at diabetes levels was 3.5 times higher than for placebos, according to documents filed in a lawsuit brought by the state of Alaska.
Dr. Kade Goepferd watched the Trump administration's moves on Thursday to ban gender-affirming care for transgender... |
 A California jury on Friday awarded $40m to two women who said Johnson & Johnson’s baby... | ||
 With subsidies for Affordable Care Act (ACA) health insurance set to expire, Americans who rely on... |
 Connecticut, Georgia, Idaho, Massachusetts, Michigan, Rhode Island, South Carolina, Texas and Puerto Rico also saw an... |
